Child and Adolescent Bipolar Disorder

This chapter summarizes current knowledge on bipolar disorder in children and adolescents—including epidemiology, risk factors, clinical presentation, diagnosis, and treatment—to inform evidence-based practice. Pediatric bipolar disorder, once thought rare, is now recognized as a valid condition with a chronic course and high comorbidity. Epidemiological studies show a stabilized prevalence in youth, and research has clarified diagnostic challenges (e.g., differentiating chronic irritability from episodic bipolarity) with the introduction of new categories like disruptive mood dysregulation disorder (DMDD). Genetic and neurobiological studies reveal a strong heritability and distinct neuroimaging findings in early-onset bipolar disorder. Clinical presentation in youth often includes mixed features, rapid mood fluctuations, and high rates of comorbid attention-deficit/hyperactivity disorder (ADHD) or other disorders. Evidence-based treatments are emerging: atypical antipsychotics have demonstrated efficacy for acute mania in youth, and mood stabilizers like lithium remain important; however, data on bipolar depression in youth are limited. Psychosocial interventions (psychoeducation, family-focused therapy, etc.) are recommended alongside medication. Early-onset (pediatric and adolescent) bipolar disorder often portends a more chronic, refractory course than adult-onset illness. Timely recognition—distinguishing it from look-alike conditions—is critical, as is a comprehensive treatment approach that addresses symptoms, functional impairment, and comorbidities. Current treatment strategies borrow from adult bipolar guidelines with necessary modifications for the developmental stage. Ongoing research is needed to refine diagnostic tools, tailor interventions for bipolar youth (especially bipolar depression and comorbid conditions), and improve long-term outcomes for this population.